MKI67 and breast carcinoma: In one study, Ki67 did not discriminate different biological subtypes of disease with distinct clinical courses rather describe the composition of the mixture of cells in the tumor, which also reflected that the heterogeneity of breast cancer might contribute to Ki67 scoring inconsistence [29].